EUPATI, the European Patients’ Academy on Therapeutic Innovation has published their Oct 2015 newsletter – learn more about the experience of students who have just completed the first Patient Xpert Training Course and why regulatory agencies think patient education and engagement are important.
- ‘Trialling tailored treatments for colorectal cancer’: A European Commission Research & Innovation Success StoryApril 16, 2018 - 10:46 am
- MErCuRIC study published in Molecular Cancer TherapeuticsMarch 6, 2018 - 10:14 am
- MErCuRIC team from RECETOX, Masarykova Univerzita publish study resultsMarch 5, 2018 - 9:11 am
MErCuRIC is funded by the European Community’s Framework Programme Seven (FP7) under contract #602901. The material presented and views expressed here are the responsibility of the author(s) only. The EU Commission takes no responsibility for any use made of the information set out.